Q9NZS9 (BFAR_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 82.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Bifunctional apoptosis regulator Alternative name(s): RING finger protein 47 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 450 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Apoptosis regulator. Has anti-apoptotic activity, both for apoptosis triggered via death-receptors and via mitochondrial factors. Ref.5 |
| Subunit structure | Interacts with CASP8, BCL2 and BCL2L1 through SAM domain and also with HIP1, IFT57, ESRRBL1 and BCAP31. Ref.1 Ref.5 |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein Ref.1 Ref.5. |
| Tissue specificity | Expressed highly in brain, moderately in small intestine, weakly in testes and only faintly in liver and skeletal muscle. Not expressed in heart, kidney, lung and spleen. Ref.1 Ref.5 |
| Sequence similarities | Contains 1 RING-type zinc finger. Contains 1 SAM (sterile alpha motif) domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Apoptosis |
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Domain | Transmembrane Transmembrane helix Zinc-finger |
| Ligand | Metal-binding Zinc |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | anti-apoptosis Inferred from direct assay Ref.1. Source: MGI apoptotic processInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | endoplasmic reticulum membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to plasma membraneTraceable author statement. Source: ProtInc membrane fractionInferred from direct assay Ref.1. Source: MGI |
| Molecular function | structural molecule activity Traceable author statement. Source: ProtInc zinc ion bindingInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 450 | 450 | Bifunctional apoptosis regulator | PRO_0000055822 | |||||
Regions | |||||||||
| Topological domain | 1 – 140 | 140 | Cytoplasmic Potential | ||||||
| Transmembrane | 141 – 161 | 21 | Helical; Potential | ||||||
| Topological domain | 162 – 331 | 170 | Lumenal Potential | ||||||
| Transmembrane | 332 – 352 | 21 | Helical; Potential | ||||||
| Topological domain | 353 – 360 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 361 – 381 | 21 | Helical; Potential | ||||||
| Topological domain | 382 – 404 | 23 | Lumenal Potential | ||||||
| Transmembrane | 405 – 425 | 21 | Helical; Potential | ||||||
| Topological domain | 426 – 450 | 25 | Cytoplasmic Potential | ||||||
| Domain | 182 – 249 | 68 | SAM | ||||||
| Zinc finger | 34 – 74 | 41 | RING-type | ||||||
Amino acid modifications | |||||||||
| Modified residue | 376 | 1 | Phosphoserine Ref.6 | ||||||
| Glycosylation | 232 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 140 | 1 | M → R. Corresponds to variant rs11546303 [ dbSNP | Ensembl ]. | VAR_052075 | |||||
| Natural variant | 245 | 1 | R → H. Corresponds to variant rs35377618 [ dbSNP | Ensembl ]. | VAR_052076 | |||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins." Zhang H., Xu Q., Krajewski S., Krajewska M., Xie Z., Fuess S., Kitada S., Pawlowski K., Godzik A., Reed J.C. Proc. Natl. Acad. Sci. U.S.A. 97:2597-2602(2000) [PubMed: 10716992] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH CASP8; BCL2 AND BCL2L1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Hepatoma. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [5] | "Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways." Roth W., Kermer P., Krajewska M., Welsh K., Davis S., Krajewski S., Reed J.C. Cell Death Differ. 10:1178-1187(2003) [PubMed: 14502241] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH IFT57; HIP1; ESRRBL1 AND BCAP31, TISSUE SPECIFICITY. |
| [6] | "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column." Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y. Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF173003 mRNA. Translation: AAF59975.1. AK291114 mRNA. Translation: BAF83803.1. CH471112 Genomic DNA. Translation: EAW85105.1. CH471112 Genomic DNA. Translation: EAW85108.1. BC003054 mRNA. Translation: AAH03054.1. |
| IPI | IPI00009811. |
| RefSeq | NP_057645.1. NM_016561.2. |
| UniGene | Hs.435556. |
3D structure databases | |
| ProteinModelPortal | Q9NZS9. |
| SMR | Q9NZS9. Positions 26-110, 170-248. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9NZS9. 9 interactions. |
| STRING | Q9NZS9. |
PTM databases | |
| PhosphoSite | Q9NZS9. |
Polymorphism databases | |
| DMDM | 74753089. |
Proteomic databases | |
| PRIDE | Q9NZS9. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000261658; ENSP00000261658; ENSG00000103429. |
| GeneID | 51283. |
| KEGG | hsa:51283. |
| UCSC | uc002dco.1. human. |
Organism-specific databases | |
| CTD | 51283. |
| GeneCards | GC16P014634. |
| H-InvDB | HIX0012831. |
| HGNC | HGNC:17613. BFAR. |
| neXtProt | NX_Q9NZS9. |
| PharmGKB | PA38460. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG09908. |
| GeneTree | ENSGT00390000005386. |
| HOGENOM | HBG714291. |
| HOVERGEN | HBG056789. |
| InParanoid | Q9NZS9. |
| OMA | FEDIQQN. |
| OrthoDB | EOG4N5VWT. |
| PhylomeDB | Q9NZS9. |
Gene expression databases | |
| ArrayExpress | Q9NZS9. |
| Bgee | Q9NZS9. |
| CleanEx | HS_BFAR. |
| Genevestigator | Q9NZS9. |
| GermOnline | ENSG00000103429. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001660. SAM. IPR013761. SAM/pointed. IPR021129. SAM_type1. IPR018957. Znf_C3HC4_RING-type. IPR001841. Znf_RING. IPR013083. Znf_RING/FYVE/PHD. IPR017907. Znf_RING_CS. [Graphical view] |
| Gene3D | G3DSA:1.10.150.50. SAM_type. 1 hit. G3DSA:3.30.40.10. Znf_RING/FYVE/PHD. 1 hit. |
| Pfam | PF00536. SAM_1. 1 hit. PF00097. zf-C3HC4. 1 hit. [Graphical view] |
| SMART | SM00184. RING. 1 hit. SM00454. SAM. 1 hit. [Graphical view] |
| SUPFAM | SSF47769. SAM_homology. 1 hit. |
| PROSITE | PS50105. SAM_DOMAIN. 1 hit. PS00518. ZF_RING_1. 1 hit. PS50089. ZF_RING_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 54523. |
Entry information
| Entry name | BFAR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NZS9 Secondary accession number(s): A8K4Z9, D3DUG8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with